BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 35460073)

  • 1. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
    Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
    Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research progress of long-chain non-coding RNA in lipid metabolism reprogramming in primary hepatocellular carcinoma].
    Yu Z; Chen DM; Huang JL
    Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):180-185. PubMed ID: 38514271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNA mediated regulation of PI3K/Akt pathway in hepatocellular carcinoma: Therapeutic perspectives.
    Hussain MS; Moglad E; Afzal M; Gupta G; Hassan Almalki W; Kazmi I; Alzarea SI; Kukreti N; Gupta S; Kumar D; Chellappan DK; Singh SK; Dua K
    Pathol Res Pract; 2024 Jun; 258():155303. PubMed ID: 38728793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
    Wong CM; Tsang FH; Ng IO
    Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming.
    Chen M; Zhang C; Liu W; Du X; Liu X; Xing B
    Mol Ther; 2022 Jun; 30(6):2354-2369. PubMed ID: 35192933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of non-coding RNAs in the metabolic reprogramming of tumor-associated macrophages.
    Li J; Lu Z; Zhang Y; Xia L; Su Z
    Immunol Lett; 2021 Apr; 232():27-34. PubMed ID: 33577913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress in the metabolic reprogramming of hepatocellular carcinoma (Review).
    Gao W; Wang J; Xu Y; Yu H; Yi S; Bai C; Cong Q; Zhu Y
    Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38818815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging roles and potential clinical applications of noncoding RNAs in hepatocellular carcinoma.
    Cao P; Jin Q; Feng L; Li H; Qin G; Zhou G
    Semin Cancer Biol; 2021 Oct; 75():136-152. PubMed ID: 32931952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.
    Shang RZ; Qu SB; Wang DS
    World J Gastroenterol; 2016 Dec; 22(45):9933-9943. PubMed ID: 28018100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long noncoding RNA
    Ren Y; Shang J; Li J; Liu W; Zhang Z; Yuan J; Yang M
    J Biol Chem; 2017 Oct; 292(43):17939-17949. PubMed ID: 28887306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional long non-coding RNAs in hepatocellular carcinoma.
    Xie C; Li SY; Fang JH; Zhu Y; Yang JE
    Cancer Lett; 2021 Mar; 500():281-291. PubMed ID: 33129957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of long noncoding RNAs in hepatocellular carcinoma.
    Huang Z; Zhou JK; Peng Y; He W; Huang C
    Mol Cancer; 2020 Apr; 19(1):77. PubMed ID: 32295598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CLINICAL SIGNIFICANCE OF NONCODING RNA IN HEPATOCELLULAR CARCINOMA].
    Eguchi H; Doki Y; Mori M
    Nihon Geka Gakkai Zasshi; 2015 Nov; 116(6):366-9. PubMed ID: 26845888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects of Noncoding RNAs in Hepatocellular Carcinoma.
    Zhou H; Xu Q; Ni C; Ye S; Xu X; Hu X; Jiang J; Hong Y; Huang D; Yang L
    Biomed Res Int; 2018; 2018():6579436. PubMed ID: 30148169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.
    Xue C; Gu X; Bao Z; Su Y; Lu J; Li L
    Front Immunol; 2022; 13():847728. PubMed ID: 35281015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
    Heo MJ; Yun J; Kim SG
    Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma.
    Niu ZS; Wang WH; Dong XN; Tian LM
    World J Gastroenterol; 2020 Aug; 26(29):4240-4260. PubMed ID: 32848331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNAs in liver cancer stem cells: The big impact of little things.
    Lv H; Lv G; Han Q; Yang W; Wang H
    Cancer Lett; 2018 Apr; 418():51-63. PubMed ID: 29307614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.